Streetbeat News

Analyst Ratings

BALY

Truist Securities analyst Barry Jonas reiterated a Buy rating on Ballys (NYSE:BALY) and maintained a $23 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 12:55 pm

AEL

Truist Securities analyst Mark Hughes reiterated a Buy rating on American Equity Inv (NYSE:AEL) and maintained a $49 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 12:54 pm

CCL

Carnival Corporation (NYSE:CCL) reported better-than-expected Q2 results with revenue of $4.91 billion and an adjusted loss of 31 cents per share. Following the announcement, analysts from Wells Fargo, Morgan Stanley, Susquehanna, and Citigroup adjusted their price targets on the stock.

Portfolio Pulse from Lisa Levin

June 27, 2023 | 12:53 pm

VSTM

Truist Securities analyst Srikripa Devarakonda has reiterated a Buy rating on Verastem (NASDAQ:VSTM) and maintained a $60 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 12:53 pm

EWTX

Truist Securities analyst Srikripa Devarakonda has reiterated a Buy rating on Edgewise Therapeutics (NASDAQ:EWTX) and maintained a $25 price target.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 12:51 pm

SPOT

Truist Securities analyst Matthew Thornton maintains a Buy rating on Spotify Technology (NYSE:SPOT) and raises the price target from $154 to $170.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 12:50 pm

GMS

Truist Securities analyst Keith Hughes maintains a Hold rating on GMS (NYSE:GMS) and raises the price target from $60 to $72.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 12:49 pm

XHR

Morgan Stanley analyst Stephen Trent maintains an Underweight rating on Xenia Hotels & Resorts (NYSE:XHR) and lowers the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 12:49 pm

AMED

Truist Securities analyst David Macdonald maintains a Hold rating on Amedisys (NASDAQ:AMED) and raises the price target from $97 to $101.

Portfolio Pulse from richadhand@benzinga.com

June 27, 2023 | 12:48 pm

WH

Morgan Stanley analyst Stephen Gengaro maintains an Overweight rating on Wyndham Hotels & Resorts (NYSE:WH) but lowers the price target from $92 to $80.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 12:47 pm